Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Hickman

Showing results (371-380 of 519) with videos related to

Pageof 52
Sort By:
BMC Infectious Diseases|July 10, 2023
Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling studyAdam Trickey, Sandra Bivegete, Erika Duffell, et al.
Hepatology (Baltimore, Md.)|February 12, 2016
Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysisNatasha K Martin, Peter Vickerman, Iain F Brew, et al.
International Journal of Epidemiology|December 31, 2013
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysisEsther J Aspinall, Dhanya Nambiar, David J Goldberg, et al.
Lancet (London, England)|October 29, 2019
Global patterns of opioid use and dependence: harms to populations, interventions, and future actionLouisa Degenhardt, Jason Grebely, Jack Stone, et al.
BMJ Open|October 12, 2023
Evaluating the impact on health outcomes of an event that resulted in a delay in contact tracing of COVID-19 cases in England, September 2020: an observational studyLucy Findlater, Livia Pierotti, Charlie Turner, et al.
BMC Public Health|September 8, 2019
Acceptability and potential impact of delivering sexual health promotion information through social media and dating apps to MSM in England: a qualitative studyJoanna M Kesten, Kaiseree Dias, Fiona Burns, et al.
Addiction (Abingdon, England)|January 30, 2023
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trialsDaniela K van Santen, Sara Lodi, Paul Dietze, et al.
Addiction (Abingdon, England)|May 12, 2020
Estimating the prevalence of problem drug use from drug-related mortality dataHayley E Jones, Ross J Harris, Beatrice C Downing, et al.
American Journal of Preventive Medicine|May 20, 2021
The Melbourne Safe Injecting Room Attracted People Most in Need of Its ServiceWijnand Van Den Boom, Maria Del Mar Quiroga, Dagnachew Muluye Fetene, et al.
Addiction (Abingdon, England)|January 24, 2019
Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugsSedona Sweeney, Zoe Ward, Lucy Platt, et al.
Pageof 52

Showing results (371-380 of 519) with videos related to

Sort By:
Pageof 52
BMC Infectious Diseases|July 10, 2023
Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling studyAdam Trickey, Sandra Bivegete, Erika Duffell, et al.
Hepatology (Baltimore, Md.)|February 12, 2016
Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysisNatasha K Martin, Peter Vickerman, Iain F Brew, et al.
International Journal of Epidemiology|December 31, 2013
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysisEsther J Aspinall, Dhanya Nambiar, David J Goldberg, et al.
Lancet (London, England)|October 29, 2019
Global patterns of opioid use and dependence: harms to populations, interventions, and future actionLouisa Degenhardt, Jason Grebely, Jack Stone, et al.
BMJ Open|October 12, 2023
Evaluating the impact on health outcomes of an event that resulted in a delay in contact tracing of COVID-19 cases in England, September 2020: an observational studyLucy Findlater, Livia Pierotti, Charlie Turner, et al.
BMC Public Health|September 8, 2019
Acceptability and potential impact of delivering sexual health promotion information through social media and dating apps to MSM in England: a qualitative studyJoanna M Kesten, Kaiseree Dias, Fiona Burns, et al.
Addiction (Abingdon, England)|January 30, 2023
Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trialsDaniela K van Santen, Sara Lodi, Paul Dietze, et al.
Addiction (Abingdon, England)|May 12, 2020
Estimating the prevalence of problem drug use from drug-related mortality dataHayley E Jones, Ross J Harris, Beatrice C Downing, et al.
American Journal of Preventive Medicine|May 20, 2021
The Melbourne Safe Injecting Room Attracted People Most in Need of Its ServiceWijnand Van Den Boom, Maria Del Mar Quiroga, Dagnachew Muluye Fetene, et al.
Addiction (Abingdon, England)|January 24, 2019
Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugsSedona Sweeney, Zoe Ward, Lucy Platt, et al.
Pageof 52